Garcia-Garcia, H.M., McFadden, E.P., von Birgelen, C., Rademaker-Havinga, T., Spitzer, E., Kleiman, N.S., Cohen, D.J., Kennedy, K.F., Camenzind, E., Mauri, L., Steg, P.G., Wijns, W., Silber, S., van Es, G.-A., Serruys, P.W., Windecker, S., Cutlip, D. and Vranckx, P. (2019) Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions, 12, 1954-1962.
https://doi.org/10.1016/j.jcin.2019.07.014

has been cited by the following article:

• TITLE: Good Outcome after More Than a Million Troponin in Serum

  AUTHORS: Mohamed Elbayomi, Timo Seitz, Michael Weyand

  KEYWORDS: Cardiac Troponin, Coronary Bypass Operation, Heart Lung Machine

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.11 No.1, January 20, 2022

  ABSTRACT: A troponin in serum of more than one Million in vivo is rare insult. We report a case of 85-year-old woman who was transferred to our institution because of acute ST elevated myocardial infarction and the troponin level reached a peak of 1,032,904.2 pg/ml. She was discharged with highly reduced left ventricular function, however in the three months follow up after a coronary bypass operation she completely was free from heart failure symptoms and echocardiography showed a totally normal function of both ventricles. This case study highlights that the initial serum troponin in acute settings can mislead the long-term prognosis and gives prominence to the expeditious myocardial revascularization.